The U.S. Food and Drug Administration today approved Intermezzo
(zolpidem tartrate sublingual tablets) for use as needed to treat
insomnia characterized by middle-of-the-night waking followed by
difficulty returning to sleep.
This is the first time the FDA has approved a drug for this condition.
Intermezzo should only be used when a person has at least four hours of
bedtime remaining. It should not be taken if alcohol has been consumed
or with any other sleep aid....
